Black Diamond Therapeutics Inc. (NASDAQ: BDTX) Stock Information | RedChip
Image

ASK REDCHAT ANYTHING ABOUT BLACK DIAMOND THERAPEUTICS INC.

Black Diamond Therapeutics Inc. (NASDAQ: BDTX)
Listen to this Section


$2.00
-0.0950 ( -4.55% ) 665.7K

Black Diamond Therapeutics Inc is a precision oncology medicine company. It is engaged in the discovery and development of small molecule, tumor-agnostic therapies. The company has one pipeline technology platform, namely Mutation-Allostery-Pharmacology, which is targeting mutations in cancer. Its drugs under the pipeline are BDTX-4933 and BDTX-1535.

Clinical Trial Pipeline Stages


Drug Name Stage
BDTX-1535DetailsCancer, Non-small cell lung carcinoma Phase 2
BDTX-1535DetailsNon-small cell lung carcinoma, Cancer Phase 2
BDTX-1535DetailsCancer, Glioblastoma Phase 1
BDTX-4933DetailsCancer Phase 1
BDTX-189 (EGFR HER2)DetailsSolid tumor/s, Cancer Failed

Market Data


Open $2.00
Previous Close $2.09
Volume 665.7K
Market Cap $120.33M
Day Range $2.00 - $2.13
52 Week Range $1.93 - $4.94
Shares Outstanding 57.30M
Change % -4.55%
Net Change ▼ -0.0950
Insider Ownership -0.02%
Exchange NASDAQ
SectorHealthcare
IndustryBiotechnology: Biological Products (No Diagnostic Substances)
IPO Year2020
CountryUnited States
UnderwriterIPO Intelligence Only

Insider Ownership Transactions

Total Amount Purchased: -1,401,109.00

Date Type Amount Purchased Purchaser
2024-06-21 Sale -2011.00 Campbell Shannon
2024-06-21 Sale -2887.00 Behbahani Ali
2024-06-21 Sale -2301.00 Raman Prakash
2024-06-06 Sale -30550.00 Menzel Garry E
2024-06-06 Sale -30550.00 Behbahani Ali
2024-06-06 Sale -30550.00 Campbell Shannon
2024-06-06 Sale -30550.00 Raman Prakash
2024-06-06 Sale -30550.00 Dhingra Kapil
2024-06-06 Sale -30550.00 Kulkarni Samarth
2024-04-12 Sale -61100.00 Raman Prakash

SEC Filings


Form Type Description Pages Date
4 Insider transactions 1 Jan 23, 2026
4 Insider transactions 1 Dec 15, 2025
4 Insider transactions 1 Dec 15, 2025
8-k 8K-related 54 Dec 03, 2025
s-3 Registration statements 19 Nov 13, 2025
10-q Quarterly Reports 65 Nov 06, 2025
8-k 8K-related 14 Nov 06, 2025
4 Insider transactions 1 Sep 22, 2025
4 Insider transactions 1 Sep 22, 2025
8-k 8K-related 14 Aug 07, 2025

Latest News


× Before browsing our site, please accept our cookies policy